Skip to main content

and
  1. Article

    Open Access

    A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

    Relatively poor penetration and retention in tumor tissue has been documented for large molecule drugs including therapeutic antibodies and recombinant immunoglobulin constant region (Fc)-fusion proteins due t...

    Lily Liu, Haijia Yu, **n Huang, Hongzhi Tan, Song Li, Yan Luo, Li Zhang in BMC Cancer (2015)

  2. Article

    Open Access

    Percutaneous transhepatic cholangial drainage or antibiotic therapy worsens response to immunotherapy in advanced cholangiocarcinoma

    Bile duct obstruction is a common issue for patients with advanced cholangiocarcinoma (CCA). Percutaneous transhepatic cholangial drainage (PTCD) is often required to relieve the obstruction. However, PTCD may...

    Qingyu Huang, Fuhao Wang, **ang Zhang, **g Liu, Xue Dou, Rui Feng, Kunli Zhu in BMC Cancer (2023)